Answers are grounded in this paper and cite their sources.
This cohort study assesses the prevalence of lupus anticoagulant (LA) positivity in patients with coronavirus disease 2019 (COVID-19) and examines the association of LA positivity with patient outcomes.
No takes yet. Share an insight, caveat, or question.
Gil et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: